First Eagle Investment Management’s Chemours CC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-717
Closed -$21.5K 394
2023
Q1
$21.5K Sell
717
-201
-22% -$6.62K ﹤0.01% 392
2022
Q4
$28.1K Hold
918
﹤0.01% 378
2022
Q3
$23K Buy
918
+455
+98% +$15K ﹤0.01% 379
2022
Q2
$15K Sell
463
-117
-20% -$4.3K ﹤0.01% 366
2022
Q1
$18K Buy
+580
New +$18.1K ﹤0.01% 366
2019
Q2
Sell
-1,876,420
Closed -$69.7M 156
2019
Q1
$69.7M Hold
1,876,420
0.19% 68
2018
Q4
$53M Buy
1,876,420
+72,965
+4% +$2.31M 0.15% 76
2018
Q3
$71.1M Buy
1,803,455
+240,950
+15% +$10.5M 0.18% 76
2018
Q2
$69.3M Buy
1,562,505
+398,515
+34% +$19.8M 0.17% 79
2018
Q1
$56.7M Buy
+1,163,990
New +$58.2M 0.14% 83
2017
Q2
Sell
-120
Closed -$5K 331
2017
Q1
$5K Hold
120
﹤0.01% 313
2016
Q4
$3K Hold
120
﹤0.01% 321
2016
Q3
$2K Hold
120
﹤0.01% 341
2016
Q2
$1K Hold
120
﹤0.01% 351
2016
Q1
$1K Hold
120
﹤0.01% 335
2015
Q4
$1K Hold
120
﹤0.01% 330
2015
Q3
$1K Buy
+120
New +$1.26K ﹤0.01% 320

Other funds holding CC

First Eagle Investment Management's CC Position: Q2 2023 in Review

First Eagle Investment Management sold out of Chemours (CC) in Q2 2023, closing a stake of 717 shares — an estimated $21.5K sold.

First Eagle Investment Management first reported a position in CC in Q3 2015 and held it in 17 quarters. The position peaked at $71.1M in Q3 2018. 476 funds tracked by Wall St. Rank hold CC as of Q2 2023.

  • First Eagle Investment Management reported no remaining Chemours position as of Q2 2023 after selling out during the quarter.
  • First Eagle Investment Management sold 717 Chemours shares in Q2 2023, an estimated $21.5K.
  • First Eagle Investment Management first reported a position in Chemours in Q3 2015 and held it in 17 quarters.
  • First Eagle Investment Management's Chemours position peaked at $71.1M in Q3 2018.
  • 476 funds tracked by Wall St. Rank held Chemours as of Q2 2023.

Based on First Eagle Investment Management's 13F filing for Q2 2023, filed 9 Aug 2023.